Prognostic Factors That Determine the Long-Term Survival of Patients with Unresectable Metastatic Melanoma-Reference-Cited by-同舟云学术

Prognostic Factors That Determine the Long-Term Survival of Patients with Unresectable Metastatic Melanoma

Published:2008-01 Issue:6 Volume:26 Page:624-633
ISSN:0735-7907
Container-title:Cancer Investigation
language:en
Short-container-title:Cancer Investigation

Author:

Bedikian Agop Y.,Johnson Marcella M.,Warneke Carla L.,Papadopoulos Nicholas E.,Kim Kevin,Hwu Wen-Jen,McIntyre Susan,Hwu Patrick

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1080/07357900802027073

Reference50 articles.

1. Lotze M. T., Dallal R. M., Kirkwood J. M., Flickinger J. C. Cutaneous melanoma. Cancer: Principles & Practice of Oncology, 6th edition, V. T. DeVita, Jr, S. Hellman, S. A. Rosenberg. Lippincott, Williams & Wilkins, Philadelphia, PA 2001; 2: 2012–2069

2. A prospective evaluation of a triple-drug regimen containing cisplatin, vinblastine, and dacarbazine (CVD) for metastatic melanoma

3. Complete responses and long-term survivals after systemic chemotherapy for patients with advanced malignant melanoma

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Classification and Staging of Melanoma in the Head and Neck;Oral and Maxillofacial Surgery Clinics of North America;2022-05

2. Association of Blood Biochemical Indexes and Antibiotic Exposure With Severe Immune-related Adverse Events in Patients With Advanced Cancers Receiving PD-1 Inhibitors;Journal of Immunotherapy;2022-03-07

3. Malignant melanoma: evolving practice management in an era of increasingly effective systemic therapies;Current Problems in Surgery;2022-01

4. Unraveling the Wide Spectrum of Melanoma Biomarkers;Diagnostics;2021-07-26

5. Clinical outcome of patients with metastatic melanoma of unknown primary in the era of novel therapy;Cancer Immunology, Immunotherapy;2021-03-27